Partnering

One element of SteriMax's business development strategy, focuses on the acquisition or in-licensing of new or mature product assets to enhance and build on our existing portfolio.

In addition to straight acquisition and in-licensing deals, opportunities exist to create synergies with international companies interested in entering the Canadian marketplace, through the formation of strategic alliances and Joint-Ventures, which can leverage the core competencies of SteriMax in North America.

Why partner with SteriMax?

An established speciality portfolio to build upon and a near-term development pipeline

A proven track record in succesful partnerships with multinational companies

Strong strategic partners in domestic and international markets

Strong partnerships with retail pharmacies including chains and independents across Canada

Strong partnerships with hospital pharmacies including all group purchasing organizations across Canada

In-depth expertise and long established relationships with Canadian and US retail distribution/wholesale networks

In-house Regulatory, QA and Clinical expertise

We are privately financed and can make strategic decisions independent of outside controlling influences

We are a flexible, responsive and accessible organization that values and nurtures its strategic partnerships

SteriMax is always looking for new products to augment our continually growing portfolio. Although we have considerable expertise in the injectable market we are also interested in oral dosages, inhalation products and other drug delivery formats across all therapeutic classes.

We would be more than happy to discuss any potential product opportunities or strategic collaborations with you, and to tell you more about our business development plans. For more information please contact:

Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it